Alten is a holding company. Through its subsidiaries, Co. operates in three areas: Engineering and Technology Consulting (ETC), Telecoms Networks and Multimedia, and Information Systems (NTIS). Through the Engineering and Technology Consulting (ETC) segment, Co. studies and designs technology products for technical divisions in industry and telecoms. The Telecoms Networks and Multimedia segment focuses on Product design, Architecture, deployment, and operation of networks. Lastly, the IT systems segment comprises Applications and software development, and Infrastructure and Telecoms (Applications, systems and networks Corporate telecommunications).
Cerinnov Group SA is a France-based company, which operates in the field of machinery for ceramic industry. The Company offers various types of machines, which are used in various stages of production of ceramics. Cerinnov Group SA's portfolio of machines includes laser machines, shaping and glazing machines, decration machines, customized machines, consumables and after sales - second hand equipment. The Company is present in worldwide, with subsidiaries in France, United Kingdom, Germany and United States.
Innate Pharma S.A. is a biopharmaceutical Company developing immunotherapy drugs for cancer and inflammatory diseases. Co. specializes in the development of new monoclonal antibodies targeting receptors and pathways controlling the activation of innate immunity cells. Also, Co. has three product-candidates resulting from its research platform are being tested in clinical trials; two of these by Co.'s partners, Bristol-Myers Squibb and Novo Nordisk A/S. Co. focuses on immunopharmacology and antibody technology. Co. has a panel of molecular and cellular assays and in vivo models for assessing the pharmacodynamics, the pharmacotoxicology and efficacy of drug candidates.
Quantel and its subsidiaries are engaged in the production, development and distribution of lasers for medical applications mainly in ophthalmology and dermatology. Co. produces lasers for scientific instrumentation involved in research and development and underwater lasers. Co. also provides laser impulses for industrial applications such as laser cleaning or material processing.
Mithra Pharmaceuticals SA is a Belgium-based company active in the pharmaceutical industry. The Company is dedicated to provide products and services for the fertility, contraception and menopause of women. It has a number of patent families regarding Estetrol (E4), a natural estrogen produced by the human foetus, which enables the investigation of fertility and contraception products. Mithra is focused on the development of two late-stage E4-based products: Estelle, a 5th generation oral contraceptive, and Donesta, a hormone therapy for Vasomotor Symptoms in menopause. Mithra develops a contraceptive vaginal ring called Myring and Zoreline, a biodegradable subcutaneous implant for hormone dependant cancer.
Pharmagest Interactive SA is a France-based company that develops and integrates management software packages for drugstores. The Company is engaged in the computerization of pharmaceutical dispensaries. Its flagship product is Integrated Portal Management Software, which provides pharmacists with permanent and immediate access to a range of online services and is used for the distribution of information and promotions for pharmaceutical suppliers and for pharmaceutical laboratories. In addition, the Company is engaged in the provision of maintenance services, technologies to manage medication compliance, as well as e-business solutions. It operates through Noviatek, Sailendra, Multimeds, British Caremeds and Axigate, among others.
SQLI SA is a France-based company that specializes in the design and creation of Information Technology (IT) systems. The Company specializes in implementing information systems based on new technologies. It operates in Business Information Systems sector, Digital Enterprise sector, E-commerce division, Communication and Organisation and management divisions. SQLI SA works with its clients from the consulting stage, through the design and installation processes, to the training and monitoring phase. The Company operates a network of offices in France, Benelux, Switzerland, Morocco and Canada, among others. It operates through brands: Wax Interactive and SQLI Enterprise. The Company has such subsidiaries as LSF Interactive, digital agency of marketing and communication, InventCommerce Ltd, a London-based Internet service provider and Star Republic, among others.
Portzamparc is a subsidary of BNP Paribas which adapted the mission to contribute to responsible and sustainable growth of private clients, management companies and SMEs . They offer personalized support adapted to the objectives in particular for Small and Medium-Sized Enterprises.
PARIS--(BUSINESS WIRE)-- Synsion BidCo, société contrôlée par un fonds d’investissement géré par des entités elles-mêmes contrôlées par DBAY Advisors Ltd (« DBAY Advisors ») a renforcé sa participation dans SQLI (Paris:SQI) par l’acquisition d’un bloc détenu par des fonds gérés par la société Otus Capital Management Limited, représentant environ 9% du capital de SQLI. DBAY Advisors qui détenait déjà 73% du capital de SQLI, détiendra à l’issue de cette acquisition 82% du capital. Cette acquisition est réalisée dans le cadre d’une transaction hors marché à un prix de 44,25 euros par action. Le...
MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that three posters showcasing IPH5201 and IPH5301 will be presented on December 8 at the 2022 European Society for Medical Oncology I-O (ESMO Immuno-Oncology) Annual Congress in Geneva, Switzerland. The following posters will be presented: IPH5201 as monotherapy or in combination with durvalumab in advanced solid tumors (AstraZeneca) Abstract Number: 472 Session Name: Poster Display 188P Session Time: 8 December, 12:30-13:15 Location:...
MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé aujourd’hui que trois posters mettant en avant IPH5201 et IPH5301 seront présentés le 8 décembre 2022 au congrès annuel de l’ESMO IO (European Society for Medical Oncology Immuno-Oncology) à Genève (Suisse). Les posters suivants seront présentés : IPH5201 as monotherapy or in combination with durvalumab in advanced solid tumors (AstraZeneca) Abstract : 472 Session : Poster Display 188P Date et heure : 8 décembre, 12h30-13h15 CET Lieu ...
LA VALEUR DU JOUR : SECHE ENVIRONNEMENT : Acquisition finalisée dans le traitement des eaux industrielles – Acheter (1), obj. 95.7€ Cours: 90.5€ au 30/11/22 VALNEVA : Les données à six mois valident le schéma vaccinal à 3 doses – Acheter (1), obj. 8.70€ Cours: 6.26€ au 30/11/22 COLLECTE / DECOLLECTE : Retour des prises de bénéfices ET AUSSI : SIGNAUX GIROD, MEDINCELL, VERIMATRIX…
Unfortunately, this report is not available for the investor type or country you selected.Browse all ResearchPool reports
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.